Epidemiologic Study to Evaluate the Proportion of Cardiovascular Disease Risk Factors in Korean Hypertensive Patients
Completed
- Conditions
- Hypertension
- Interventions
- Other: Blood Sampling
- Registration Number
- NCT01362283
- Lead Sponsor
- GlaxoSmithKline
- Brief Summary
The purpose of this study is investigating the proportion of Cardiovascular disease risk factors of hypertensive patients.
- Detailed Description
Primary endpoint: To evaluate the Proportion of patients with Cardiovascular disease high risk factors
Secondary endpoint: To evaluate the Proportion of patients with Cardiovascular disease risk factors, To evaluate the Proportion of patients with Cardiovascular disease, To evaluate Target blood pressure achievement rate according to the proportion of Cardiovascular disease risks
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3109
Inclusion Criteria
- Essential hypertensive patient no less than 18 yeas old
- Patient who gave informed consent form
Exclusion Criteria
- Patient was diagnosed as secondary hypertension
- Patient who have white-coat hypertension
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Hypertension Blood Sampling Subject who meet eligible criteria
- Primary Outcome Measures
Name Time Method Proportion of patients with cardiovascular disease high risk factors 6years, average duration of hypertension Between patients with essential hypertension
- Secondary Outcome Measures
Name Time Method Proportion of patients with Cardiovascular disease 6years, average duration of hypertension Between patients with essential hypertension
Proportion of patients with Cardiovascular disease risk factors 6years, average duration of hypertension Between patients with essential hypertension
Target Blood Pressure achievement rate according to the proportion of Cardiovascular disease risks 6years, average duration of hypertension Between patients with essential hypertension